Evidence map›Paper›PMID 38856947›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.

Takaaki Hasegawa, Toru Okuyama, Takehiro Uemura, Yoshinobu Matsuda, Hiroyuki Otani, Junichi Shimizu, Yoshitsugu Horio, Naohiro Watanabe, Teppei Yamaguchi, Satoshi Fukuda and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Takaaki HasegawaCenter for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0001-7894-4528
Toru OkuyamaCenter for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan. okuyama@med.nagoya-cu.ac.jp.ORCID https://orcid.org/0000-0003-0504-6406
Takehiro UemuraDepartment of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0001-6732-5625
Yoshinobu MatsudaDepartment of Psychosomatic Internal Medicine, NHO, Kinki-Chuo Chest Medical Center, 1180 Nagasnone-cho, Kita-ku, Sakai, Osaka, 591-8025, Japan.ORCID https://orcid.org/0000-0001-5092-9377
Hiroyuki OtaniDepartment of Palliative Care Team, Palliative and Supportive Care, NHO Kyushu Cancer Center, 3-1-1 Notame, Mitami-ku, Fukuoka, Fukuoka, 811-1395, Japan.ORCID https://orcid.org/0000-0002-2437-4344
Junichi ShimizuDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Yoshitsugu HorioDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Naohiro WatanabeDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Teppei YamaguchiDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Satoshi FukudaDepartment of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0001-6576-7112
Tetsuya OguriDepartment of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0002-3796-7915
Ken MaenoDepartment of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0002-4561-4044
Yuji InagakiDepartment of Internal Medicine, NHO, Kinki-Chuo Chest Medical Center, 1180 Nagasnone-cho, Kita-ku, Sakai, Osaka, 591-8025, Japan.ORCID https://orcid.org/0000-0002-2208-9478
Kaname NosakiDepartment of Thoracic Oncology, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka-shi, Fukuoka, 811-1395, Japan.ORCID https://orcid.org/0000-0002-1800-9455
Kensuke FukumitsuDepartment of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0003-1506-7104
Tatsuo AkechiCenter for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.ORCID https://orcid.org/0000-0003-1100-7518

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDetermining whether patients' unrealistic expectations of chemotherapy as a cure were associated with their perception of the disclosure of incurability.

methodsThis prospective study included consecutive patients with pretreated non-small cell lung cancer from four study sites. Patients and their oncologists were asked whether they perceived the disclosure of cancer incurability. Patients were also asked if they thought that chemotherapy was curative. We followed up on whether the deceased patients received specialized palliative care 14 months after their last enrollment. Multiple regression analyses were conducted to examine the association between the expectation of chemotherapy as a cure and patient/oncologist-reported perceptions of the disclosure of incurability.

resultsWe analyzed 200 patients, 77 (38.5%) of whom had unrealistic expectations of a cure. Based on patients' perceptions, incurability was disclosed to 138 (69.0%) patients, and based on their oncologists' perceptions, incurability was disclosed to 185 (92.5%) patients (patient/oncologist agreements, κ = 0.19). Patients without a perception of the oncologist's disclosure of incurability-regardless of their oncologist's perception-were more likely to have unrealistic expectations of a cure than patients for whom both patient and oncologist perceptions were present. Patients who had unrealistic expectations of chemotherapy as a cure were shown to be significantly less likely to have received specialized palliative care, after adjusting for covariates (adjusted OR, 0.45; 95% CI, 0.23-0.91; p = .027).

conclusionOncologists' disclosure of incurability was not fully recognized by patients, and expectations of chemotherapy as a cure were associated with patients' perception of the disclosure of incurability.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsPalliative CareAdultAgedAged, 80 and overAntineoplastic AgentsFemaleHumansMaleMiddle AgedPhysician-Patient RelationsProspective StudiesRegression AnalysisTruth DisclosureAntineoplastic AgentsAdvance care planningCommunicationEnd-of-life discussionLung cancerNeoplasmPalliative care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.